We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.1B
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
-0.97%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$3.55B
AUM Growth
+$133M
Cap. Flow
+$228M
Cap. Flow %
6.44%
Top 10 Hldgs %
31.71%
Holding
123
New
40
Increased
24
Reduced
23
Closed
30

Top Buys

Rank Stock Value
1
ELV icon
Elevance Health
ELV
+$71.8M
2
ABBV icon
AbbVie
ABBV
+$63.8M
3
CI icon
Cigna
CI
+$62.3M
4
PBYI icon
Puma Biotechnology
PBYI
+$49.5M
5
UNH icon
UnitedHealth
UNH
+$44.3M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$99.2M
2
META icon
Meta Platforms (Facebook)
META
+$73.1M
3
BAX icon
Baxter International
BAX
+$70M
4
NOW icon
ServiceNow
NOW
+$67.7M
5
V icon
Visa
V
+$65.5M

Sector Composition

Rank Sector Weight
1 Healthcare 40.7%
2 Technology 6.07%
3 Energy 6.01%
4 Industrials 3.89%
5 Communication Services 3.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KMX icon
51
CarMax
KMX
$8.29B
$21.2M 0.6%
+329,301
New +$18.5M
HON icon
52
Honeywell
HON
$77.9B
$20.8M 0.59%
+198,805
New +$20.2M
SCHW
53
Charles Schwab
SCHW
$181B
$20.7M 0.58%
+523,388
New +$18.7M
PDCO
54
DELISTED
Patterson Companies, Inc.
PDCO
$20.5M 0.58%
+499,330
New +$21.5M
AMAT icon
55
Applied Materials
AMAT
$410B
$19.9M 0.56%
+617,952
New +$18.8M
MYOK
56
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$19.7M 0.56%
1,524,585
+331,548
+28% +$5.11M
VYGR icon
57
Voyager Therapeutics
VYGR
$187M
$17.6M 0.5%
1,384,151
+26,178
+2% +$336K
OVV icon
58
Ovintiv
OVV
$16.6B
$17.5M 0.49%
+297,587
New +$17M
ALXN
59
DELISTED
Alexion Pharmaceuticals
ALXN
$16.3M 0.46%
+133,605
New +$16.3M
ZLTQ
60
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
$16.1M 0.46%
371,061
-84,525
-19% -$3.41M
CME icon
61
CME Group
CME
$91.8B
$14.9M 0.42%
129,540
-386,085
-75% -$43M
XBI icon
62
CALL
State Street SPDR S&P Biotech ETF
XBI
$10.2B
$14.9M 0.42%
+250,900
New +$15.5M
PEN icon
63
Penumbra
PEN
$12.6B
$14.8M 0.42%
231,892
+24,427
+12% +$1.63M
ARAY icon
64
Accuray
ARAY
$26.8M
$14.7M 0.41%
3,193,555
-1,026,718
-24% -$5.33M
MTD icon
65
Mettler-Toledo International
MTD
$27B
$14.6M 0.41%
+34,936
New +$14.5M
TEX icon
66
Terex
TEX
$7.89B
$14.5M 0.41%
+461,197
New +$12.8M
PTLA
67
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$13M 0.37%
+578,150
New +$11.3M
VMC icon
68
Vulcan Materials
VMC
$36.9B
$11.9M 0.34%
95,398
– –
KURA icon
69
Kura Oncology
KURA
$901M
$11.7M 0.33%
1,978,429
-29,213
-1% -$157K
MOH icon
70
Molina Healthcare
MOH
$10.4B
$11.1M 0.31%
204,110
-196,643
-49% -$10.8M
CSII
71
DELISTED
Cardiovascular Systems, Inc.
CSII
$10.5M 0.3%
432,940
-69,105
-14% -$1.7M
BAC icon
72
Bank of America
BAC
$436B
$10.3M 0.29%
+467,862
New +$9.01M
ARCH
73
DELISTED
Arch Resources, Inc.
ARCH
$10.3M 0.29%
+131,767
New +$9.96M
GDDY icon
74
GoDaddy
GDDY
$12.8B
$10M 0.28%
+286,962
New +$10.1M
HDS
75
DELISTED
HD Supply Holdings, Inc.
HDS
$9.84M 0.28%
+231,562
New +$8.54M
1 2
3
4 5

Similar funds

DAM
Delta Asset Management Memphis, Tennessee $1.1B AUM 14.89% 1-Year Est. Return
MAM
Mark Asset Management New York $1.1B AUM 43.79% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.1B AUM 61.65% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return
CF
Corebridge Financial Houston, Texas $1.09B AUM 1.85% 1-Year Est. Return
MIA
MMBG Investment Advisors Miami, Florida $1.09B AUM 30.96% 1-Year Est. Return

PFM Health Sciences's Q4 2016 Portfolio in Review

As of Q4 2016, PFM Health Sciences held 123 positions worth $3.55B, up 3.9% from $3.42B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

PFM Health Sciences deployed $228M of net new capital in Q4 2016, opening 40 new positions and adding to 24 existing holdings. Its largest new stake was Elevance Health: 536,457 shares worth $77.1M.

By sector, the portfolio is most concentrated in Healthcare at 41% of assets, up from 37% a quarter earlier, followed by Technology and Energy.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $73.1M trimmed.

  • PFM Health Sciences's largest Q4 2016 buy was Elevance Health: 536,457 shares worth $77.1M.
  • PFM Health Sciences added most to AbbVie in Q4 2016, an estimated $63.8M increase.
  • PFM Health Sciences's biggest Q4 2016 reduction was Meta Platforms (Facebook), cutting an estimated $73.1M.
  • PFM Health Sciences fully exited Apple in Q4 2016, selling an estimated $99.2M.
  • PFM Health Sciences's ten largest holdings make up 32% of its $3.55B portfolio in Q4 2016.
  • PFM Health Sciences opened 40 new positions and closed 30 in Q4 2016.
  • PFM Health Sciences's portfolio value rose 3.9% quarter-over-quarter to $3.55B.

Based on PFM Health Sciences's 13F filing for Q4 2016, filed 14 Feb 2017.